Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources.

Valentina PerroneChiara VeronesiMelania DovizioDomenica Daniela AnconaMargherita AndrettaFausto BartoliniArturo CavaliereAlessandro ChinellatoAndrea CiacciaMariarosaria CilloAdele De FrancescoNicola EnieriFulvio FerranteSimona GentileCataldo ProcacciLoredana UbertazzoAdriano VercelloneDomenico LucatelliMichela ProcacciniLuca Degli Esposti

Published in: ClinicoEconomics and outcomes research : CEOR (2022)

The present analysis conducted in a setting of Italian clinical practice has shown that 25% of patients with focal epilepsy were resistant to antiepileptic treatments. Furthermore, these results showed that health-care costs for the management of epileptic patients were mainly accountable for the costs related to the disease-management and to hospitalizations.

Keyphrases

drug resistant
healthcare
multidrug resistant
end stage renal disease
clinical practice
acinetobacter baumannii
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
pseudomonas aeruginosa
patient reported
affordable care act